0001104659-24-047885.txt : 20240416
0001104659-24-047885.hdr.sgml : 20240416
20240416171534
ACCESSION NUMBER: 0001104659-24-047885
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240412
FILED AS OF DATE: 20240416
DATE AS OF CHANGE: 20240416
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JEFFS ROGER
CENTRAL INDEX KEY: 0001231615
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39724
FILM NUMBER: 24848671
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Liquidia Corp
CENTRAL INDEX KEY: 0001819576
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 851710962
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 419 DAVIS DRIVE, SUITE 100
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
BUSINESS PHONE: 919.328.4400
MAIL ADDRESS:
STREET 1: 419 DAVIS DRIVE, SUITE 100
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
4
1
tm2411915-2_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-04-12
0
0001819576
Liquidia Corp
LQDA
0001231615
JEFFS ROGER
419 DAVIS DRIVE, SUITE 100
MORRISVILLE
NC
27560
1
1
0
0
Chief Executive Officer
1
Common Stock
2024-04-12
4
S
0
8360
14.58
D
826985
D
Common Stock
46595
I
See footnote
Common Stock
1541667
I
See footnote
Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023.
These shares of common stock were sold to cover taxes associated with the settlement of restricted stock units ("RSUs") that were initially granted to the Reporting Person on January 11, 2023.
Includes (i) 199,031 unvested RSUs of the 289,500 RSUs granted to the Reporting Person on January 11, 2023, (ii) 221,338 unvested RSUs granted to the Reporting Person on January 11, 2024, none of which have vested as of the date of this Form 4, and (iii) 7,169 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.
The securities are held by Roger A. Jeffs Living Trust UAD 2/29/2000 (the "Trust"). The Reporting Person is the trustee of the Trust.
The securities are held by Serendipity BioPharma LLC ("Serendipity"). The Reporting Person is a manager of Serendipity and has sole voting and dispositive power over the Issuer common stock held by Serendipity.
/s/ Roger Jeffs
2024-04-16